Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
China Journal of Chinese Materia Medica ; (24): 2341-2344, 2014.
Article in Chinese | WPRIM | ID: wpr-330293

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the mechanism that the formulas for activating blood and resolving stasis can regulate hemopoietic stem cell to produce new blood.</p><p><b>METHOD</b>Rats were established animal model of acute cerebral infarction by referencing Olivette' method. They were randomly divided into model group, the group of the high, middle, low dose of the formulas for activating blood and resolving stasis. Each group and then wasrandomly divided into subgroups by 1, 3, 7, 14, 28 d. Xuesaitong capsule was formulated into 20, 40, 60 g x L(-1) with normal saline. The rats were given gavage drugs once a day until the experient ended, and the model group was administrated by intragastrical perfusion of normal saline. ELISA was used to detect the expression of SCF in peripheral blood and bone marrow among different groups at different time points. Flow cytometry was used to observe the changes of CD117 in blood and bone marrow.</p><p><b>RESULT</b>The CD117+ HSC and SCF concentration in peripheral blood and bone marrow of model group were increasing during 1-14 d,there was a peak on the 14th day, then the expression was reducing. CD117+ HSC and SCF concentration rising trend in the group of the high, middle dose of the formulas for activating blood and resolving stasis was preceded model group (P < 0.05).</p><p><b>CONCLUSION</b>Activating blood and resolving stasis can regulate hemopoietic stem cell to produce new blood, and it is through the regulation of CD117+ HSC number to achieve the purpose.</p>


Subject(s)
Animals , Humans , Male , Rats , Bone Marrow Cells , Metabolism , Capsules , Cerebral Infarction , Blood , Drug Therapy , Genetics , Metabolism , Chemistry, Pharmaceutical , Drugs, Chinese Herbal , Hematopoietic Stem Cells , Metabolism , Proto-Oncogene Proteins c-kit , Genetics , Metabolism , Rats, Sprague-Dawley , Stem Cell Factor , Genetics , Metabolism
2.
China Journal of Orthopaedics and Traumatology ; (12): 805-807, 2009.
Article in Chinese | WPRIM | ID: wpr-361070

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the clinical effects of treatment for superior tibial fracture complicating with crotch injury of distal popliteal artery by an alternative micro-surgical operation.</p><p><b>METHODS</b>During Feb. 2002 to Oct. 2007, there were 19 patients with superior tibial fracture complicating with crotch injury of distal popliteal artery included 15 males and 4 females aged from 21 to 48 years (means 35 years). There were 6 cases complicating with fracture of tibial plateau, 3 cases complicating with nerve injury. The tibial fracture were fixed with external fixator and the anterior tibial artery and vein and posterior tibial artery and vein were treated by transplantable great saphenous vein (Y-shape) combined with windowing for interosseous membrane by the posterior and anterolateral incision. Evaluations of clinical effect were performed according to Rasmussen functional score system.</p><p><b>RESULTS</b>All patients survived after operation. All fracture achieved bony union, the union time was from 3 to 14 months (means 5.5 months). All patients were followed-up for from 8 to 23 months (means 13 months). The mean Rasmussen functional score was (27.0 + 2.9). The results were excellent in 11 cases, good in 7, and fair in 1.</p><p><b>CONCLUSION</b>The surgical exploration should be done as soon as possible when diagnosis of injuries of large arteries is definite or highly suspected. Simultaneous reconstruction of both posterior tibial artery and anterior tibial artery associated with vein can reduce the rate of disability and recover function of limb.</p>


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Young Adult , Follow-Up Studies , Groin , General Surgery , Microsurgery , Popliteal Artery , Wounds and Injuries , General Surgery , Plastic Surgery Procedures , Tibial Fractures , Diagnosis , Therapeutics
3.
Acta Academiae Medicinae Sinicae ; (6): 326-329, 2009.
Article in Chinese | WPRIM | ID: wpr-259019

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effect of calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine (EBB) on proliferation of human breast cancer cell MCF-7 and its possible mechanism.</p><p><b>METHODS</b>MTT assay was used to analyze the effect of EBB on tumor cells growth. Flow cytometry was used to detect its impact on the cell cycle of MCF-7 cells. Immunofluoresce labeling technique and laser scanning confocal microscope were used to reveal the changes of the microtubule, microfilament, mitochondrion, and endoplasmic reticulum in the cells.</p><p><b>RESULTS</b>The IC50 value of EBB in MCF-7 cells was (13.0 +/- 3.7) micromol/L. MCF-7 cells were arrested at S phase after EBB treatment. Meanwhile, depolymerization of the microtubule and microfilament, impairment of the mitochondrion and swelling of endoplasmic reticulum were observed.</p><p><b>CONCLUSION</b>EBB arrests MCF-7 cells at S phase by inhibiting the growth of MCF-7 cells, which may be related to the changes of structures and functions of the microtubule, microfilament, mitochondrion, and endoplasmic reticulum.</p>


Subject(s)
Female , Humans , Benzylisoquinolines , Pharmacology , Breast Neoplasms , Pathology , Calmodulin , Cell Cycle , Cell Line, Tumor , Cell Proliferation
4.
China Journal of Orthopaedics and Traumatology ; (12): 1-3, 2009.
Article in Chinese | WPRIM | ID: wpr-258143

ABSTRACT

<p><b>OBJECTIVE</b>To compare the effect between mini-traumatic bone-grafting and non-bone-grafting in percutaneous K-wire fixation for treating the calcaneal fractures.</p><p><b>METHODS</b>From 2002 to 2006, 112 patients with the type II (Paley type) fractures of calcaneus were studied. There were 56 cases in bone-grafting group involving 36 males and 20 famales,aged from 21 to 65, averaged (42.0 +/- 2.3) years; 11 cases were in type II a and 45 were in type II b; the course was from 3 to 14 days, averaged (6.0 +/- 1.2) days. And there were 56 cases in non-bone-grafting group involving 38 males and 18 famales,aged from 22 to 67, averaged (43.0 +/- 2.5)years; 13 cases were in type II a and 43 were in type II b; the course was from 2 to 15 days, averaged (5.0-2.1) days. All the cases were treated by closed reduction and percutaneous K-wire fixation, and bone-grafting group(56 cases) were treated by mini-traumatic bone-grafting, but the other group (56 cases) were not. The collapsing rate and fineness rate were compared.</p><p><b>RESULTS</b>All the cases were followed up from 5 to 52 months. There were no collapsing cases in the bone-grafting group after operation, but 3 cases occurrenced re-collapsing in the non-bone-grafting group. According to the Zhang Tie-liang's evaluation criterion, in the bone-grafting group,the results were excellent in 43 cases, good in 12, fair in 1, the fineness rate was 98.2%. In the non-bone-grafting group,the results were excellent in 37 cases, good in 16, fair in 2, poor in 1, the fineness rate was 94.7%.</p><p><b>CONCLUSION</b>Treatment of the type II fracture of calcaneus with closed reduction, percutaneous K-wire fixation and mini-traumatic bone-grafting can prevent the posterior talar articular surface of caltaneus from collapsing again after operation, enhance the union of fracture, elevate the curative effect, thus it should be taken with the standard therapeutic regimen.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Bone Transplantation , Methods , Bone Wires , Calcaneus , Wounds and Injuries , General Surgery , Follow-Up Studies , Fracture Fixation, Internal , Fractures, Bone , General Surgery , Transplantation, Autologous , Treatment Outcome
5.
Acta Academiae Medicinae Sinicae ; (6): 164-168, 2006.
Article in Chinese | WPRIM | ID: wpr-281240

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the reversal effect of O-(4-ethoxyl-butyl)-berbamine (EBB) on multidrug resistance (MDR) in MCF-7/ADR cell.</p><p><b>METHODS</b>3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) assay was used to assess the antitumor effect of EBB and determine the reversal effects of different concentrations ( < or = IC20) of EBB on MCF-7/ADR cell. Flow cytometry was applied to observe the intracellular accumulation of Rh123 and cell cycle in the presence of EBB. The expressions of MDR-related genes mdr 1 and topoisomerase II b (top II b) were evaluated by reverse transcription-polymerase chain reaction.</p><p><b>RESULTS</b>The sensitivity of MCF-7/ADR to adriamycin (ADR) was enhanced up to 50. 40, 89.80, and 14.88 folds after exposure of the cells to 3 micromol/L EBB, 7.5 micromol/L EBB, and 10 micromol/L verapamil (VPL), respectively. After 2 hours of incubation with 6 micromol/L EBB, intracellular Rh123 accumulation in MCF-7/ADR cells was increased to the level comparable to that in MCF-7 cells. When 6 micromol/L EBB was added together with 2 micromol/L ADR, MCF-7/ ADR cells showed to be arrested in the G2/M phase. The declination of mdr 1 gene expression was observed when 6 micromol/L EBB, 12 micromol/L EBB, and 10 micromol/L VPL were added for 48 hours; meanwhile, the expression of top II b mRNA showed no significant change.</p><p><b>CONCLUSION</b>EBB has a strong reversal effect on MDR in MCF-7/ ADR cell, which may be achieved by enhancing the arrestment of MCF-7/ADR cells at G2/M phase and increasing intracellular drug concentration.</p>


Subject(s)
Female , Humans , ATP Binding Cassette Transporter, Subfamily B, Member 1 , Metabolism , Antineoplastic Agents , Pharmacokinetics , Pharmacology , Benzylisoquinolines , Pharmacology , Breast Neoplasms , Pathology , Calmodulin , Cell Cycle , Cell Line, Tumor , Doxorubicin , Pharmacokinetics , Pharmacology , Drug Interactions , Drug Resistance, Multiple , Drug Resistance, Neoplasm
6.
Acta Academiae Medicinae Sinicae ; (6): 311-314, 2005.
Article in Chinese | WPRIM | ID: wpr-343716

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the potential effect of EBB, a calmodulin antagonist, on invasion of human fibrosarcoma cells HT1080.</p><p><b>METHODS</b>The antitumor effect of EBB was assessed by 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Activities of matrix metalloproteinase (MMP)-2 and MMP-9 were measured by Zymogrophy analysis. The mRNA levels, of MMP-2, MMP-9, and tissue inhibitor of metalloproteinases (TIMP)-1 were evaluated by reverse transcriptionpolymerase chain reaction (RT-PCR). Transwell chamber assay was applied to measure the effect of EBB on the invasion of HT1080 cells.</p><p><b>RESULTS</b>Calmodulin antagonist EBB inhibited the proliferation of HT1080 cells with an IC50 of (8.2 +/- 1.2) microg/ml. EBB down-regulated the activities of MMP-2 and MMP-9, and down-regulated the mRNA levels of MMP-2 and MMP-9, while up-regulated the mRNA levels of TIMP-1. The invasive ability of HT1080 cells was decreased to (31.13 +/- 2.265)%, (59.91 +/- 2.566)%, and (71.58 +/- 0.5960)% after exposure of the cells with 2, 5, and 10 microg/ml EBB, respectively.</p><p><b>CONCLUSION</b>Treatment with calmodulin antagonist EBB is effective in suppressing tumor invasion. The possible mechanism is the down-regulation of MMPs.</p>


Subject(s)
Humans , Antineoplastic Agents , Pharmacology , Benzylisoquinolines , Pharmacology , Calmodulin , Cell Line, Tumor , Down-Regulation , Fibrosarcoma , Pathology , Matrix Metalloproteinase 2 , Genetics , Matrix Metalloproteinase 9 , Genetics , Neoplasm Invasiveness , RNA, Messenger , Genetics
7.
Acta Academiae Medicinae Sinicae ; (6): 38-42, 2004.
Article in Chinese | WPRIM | ID: wpr-326987

ABSTRACT

<p><b>OBJECTIVE</b>To study whether intraspinally transplanted human cord blood CD34+ cells can survive, differentiate, and improve neurological functional recovery after spinal cord injury in rats.</p><p><b>METHODS</b>Rats were randomly divided into two groups. One group of rats was subjected to spinal cord left-hemisection and transplanted with human cord blood CD34+ cells labeled by bromodeoxyuridine (BrdU); The other group was carried by left-hemisection with injection of PBS (control group). The neurological function was determined before and 24 h, 1, 2, 3 and 4 weeks after spinal cord injury and cell transplantation using the modified Tarlov score. The distribution and differentiation of transplanted human cord blood cells in vivo in rat spinal cord were evaluated by histological and immnuhistochemical analysis.</p><p><b>RESULTS</b>Functional recovery determined by modified Tarlov score was significantly improved in the group receiving human cord blood CD34+ cells compared with the control group (P < 0.05). Moreover, human cord blood CD34+ cells were found to survive in rat spinal cord microenvironment, with the expression of the neural nuclear specific protein (NeuN) in 2% BrdU-reactive human cells and of the astrocytic specific protein glial fibrillary acidic protein (GFAP) in 7% BrdU-reactive human cells.</p><p><b>CONCLUSIONS</b>Intraspinally administered human cord blood CD34+ cells can survive, differentiate, and improve functional recovery after spinal cord injury in rats. Transplantation of human cord blood cells may provide a novel strategy for the treatment of neural injury.</p>


Subject(s)
Animals , Female , Humans , Male , Rats , 4-Hydroxycoumarins , Antigens, CD34 , Metabolism , Fetal Blood , Cell Biology , Random Allocation , Rats, Wistar , Recovery of Function , Spinal Cord Injuries , General Surgery , Stem Cell Transplantation
SELECTION OF CITATIONS
SEARCH DETAIL